MODIFIZIERTE MIKROCYSTINE

European patent · EP3555117 · In force

Register entry

Publication number
EP3555117
Application number
EP18740103
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 9, 2018
Published
Oct 23, 2019
Granted
Jan 8, 2020
Protection ends at the latest
May 8, 2038
Next annual fee due
May 31, 2027
IPC classes
C07K 7/64 (2006.01)
A61K 38/00 (2006.01)
A61K 47/50 (2017.01)
A61K 47/68 (2017.01)
Priority
EP 17170283 09.05.2017
PCT application
PCT/EP2018/062129 09.05.2018
PCT publication
WO2018/206715 15.11.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Mar 13, 2020

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 13.03.2020

  6. Jan 8, 2020

    Granted

    Published in Swissreg on 08.01.2020

Parties

Holder

Cyano Biotech GmbH

Magnusstrasse 11, 12489 Berlin, DE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

NIEDERMEYER, Timo

06114 Halle Saale, DE

ENKE, Heike

12307 Berlin, DE

LORENZEN, Wolfram

10779 Berlin, DE

ENKE, Dan

12307 Berlin, DE

JAHNS, Stefan

10243 Berlin, DE

MOSCHNY, Julia

92237 Sulzbach-Rosenberg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.